AC
CNMD icon

Ascend Capital’s CONMED CNMD Stock Holding History

Ascend Capital’s Portfolio CNMD Stock Details CNMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-75,650
Closed -$3.36M – 163
2017
Q1 		$3.36M Buy
+75,650
New +$3.25M 0.15% 113
2014
Q2 		– Sell
-117,100
Closed -$5.09M – 180
2014
Q1 		$5.09M Buy
117,100
+27,156
+30% +$1.21M 0.13% 145
2013
Q4 		$3.82M Sell
89,944
-21,275
-19% -$808K 0.12% 145
2013
Q3 		$3.78M Buy
+111,219
New +$3.63M 0.14% 153

Other funds holding CNMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
CRM
Cramer Rosenthal McGlynn Stamford, Connecticut $1.36B AUM 31.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Ascend Capital's CNMD Position: Q2 2017 in Review

Ascend Capital sold out of CONMED (CNMD) in Q2 2017, closing a stake of 75,650 shares — an estimated $3.36M sold.

Ascend Capital first reported a position in CNMD in Q3 2013 and held it in 4 quarters. The position peaked at $5.09M in Q1 2014. 150 funds tracked by Wall St. Rank hold CNMD as of Q2 2017.

  • Ascend Capital reported no remaining CONMED position as of Q2 2017 after selling out during the quarter.
  • Ascend Capital sold 75,650 CONMED shares in Q2 2017, an estimated $3.36M.
  • Ascend Capital first reported a position in CONMED in Q3 2013 and held it in 4 quarters.
  • Ascend Capital's CONMED position peaked at $5.09M in Q1 2014.
  • 150 funds tracked by Wall St. Rank held CONMED as of Q2 2017.

Based on Ascend Capital's 13F filing for Q2 2017, filed 11 Aug 2017.